PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
about
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.Therapeutic Targeting of PP2A.Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
P2860
PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@en
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@nl
type
label
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@en
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@nl
prefLabel
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@en
PP2A inhibition with LB100 enh ...... ance in medulloblastoma cells.
@nl
P2093
P2860
P356
P1433
P1476
PP2A inhibition with LB100 enh ...... tance in medulloblastoma cells
@en
P2093
Abhik Ray-Chaudhury
Dragan Maric
Gerald M Feldman
Juan-Carlos Vera
Lauren Amable
Martin J Lizak
Matthew D Hall
Michael J Feldman
Winson S Ho
Zhengping Zhuang
P2860
P304
12447-12463
P356
10.18632/ONCOTARGET.6970
P407
P577
2016-03-01T00:00:00Z